In a systematic review, researchers found inadequate evidence to determine if intravenous vitamin C was beneficial for cancer treatment
Key results and Safety After 68 weeks of treatment, people taking cagrilintide 2.4 mg once weekly lost an average of 11.8% of their body weight, which was about 12.5 kilograms
That suggests it could be useful as a complementary therapy when these other medications are prescribed
The vitamins and minerals themselves follow their own timeline once inside the body
Topical applications generally produce more gradual improvements over time
Yet another strategy is to use a molecular degrader of extracellular proteins, which links a target-binding unit (for instance binding to IgG, as with BHV-1300 [418]) to a motif that binds asialoglycoprotein receptors (ASGPR) to direct its targets to endolysosomal degradation in the liver [419, 420]